You can adjust the categories of cookies you wish to allow for any tracking technology used for the provision of services. You can change your preferences at any time by clicking the apposite button. For more information, refer to the Cookie Policy.
We close the week with very good news! We are very happy to be part of CataloniaBio & HealthTech joining the +200 leading com...
Join us at Pharma Partnering Summit 2022! 📢 This week, we will be attending Pharma Partnering Summit taking place on 12th & 1...
This week, our #CEO and President of Medicines for Europe, Elisabeth Stampa visited the European Commission. She met and e...
At Medichem, we invest in new products, applications, and technologies and encourage our teams to develop new ideas and bring them to success....
At Medichem, we are excited to announce that we will participate for the 1st year. If you want to set up a meeting there, please contact us at...
#Chlorhexidine and #Octenidine are increasingly being used not only as an antiseptic to prevent hospital infections and as an adjuvant in oral...
Have you registered for our upcoming #webinar? #23: Challenges, experience, and solutions scaling up flow chemistry Live session: Tuesday, ...
In Medichem, we are happy to announce our participation in #euroPLX78, April, 4th & 5th. It would be a pleasure to meet you. Please con...
#dcat is just around the corner! Only one week to go. The #Medichemteam will be participating. Don't miss the chance to meet and discuss your ...
This year, we celebrate our 50th #anniversary in the global #generic pharma industry. During these 50 years, in Medichem, we have been at t...
It is an honor to share that our CEO Elisabeth Stampa will start the new mandate as #president of Medicines for Europe for the next two years....
Last week we shared our experiences in an event organized by The Embassy of the Republic of Malta in Spain and the Madrid ...
Last week was very exciting, our CEO Elisabeth Stampa and the whole team of Medichem Manufacturing (Malta) Ltd. had the pleasure to greet some dis...
Our CEO Elisabeth Stampa today in DCAT (Drug, Chemical & Associated Technologies Association) Values Chain Insights: 5 Minutes With. T...
COVID crisis revealed the problems generated when Europe became too dependent on critical products manufactured overseas. Si...
13th edition, 30 countries involved, more than 12,000 actions…. The European Week for Waste Reduction is coming to an end, but it's not just a mat...
The project "Research and development of a drug for the treatment of acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma...
Last week our CEO Elisabeth Stampa won the #eWoman award for Career Achievement by CaixaBank. This award promotes equality and progress throug...
We made a nice start and we are finished today. Team is super happy. We have missed many colleagues and partners but grateful for those who st...
One step further with Apixaban. We are happy to announce that Apixaban API has been approved by China NMPA. 🎉🎉 This is a significant milest...
After one year break due to COVID 19, two weeks ago, we all gathered for the Annual Conference of Medicines for Europe, we share the main...
We would like to congratulate our CEO Elisabeth Stampa, who is eligible for the national award and to be one of the Spanish representatives of...
In 2020, CPhI was unfortunately cancelled and we did not have the opportunity to meet industry colleagues. This year CPhI will be happeni...
Medichem's Management Team met late July to further analyze how to continue improving the service provided to our partners and customers and hel...
Medichem has joined Kemiex platform to explore new opportunities and make its products and support further available.
Medichem has joined Bioseet platform to expand its customer base and explore new potential cooperations worldwide.
We have so many new things to explain that we would love to meet you! If you want to hear more, book a slot with us!
We are pleased to announce that this week we received the confirmation of the launch of Prucalopride in Europe. This is a 100% vertically inte...
Ms. Mariona Senis, Quality Director of Medichem, S.A., participated as a guest speaker in the training program on Indicators of the Quality Sy...
Find out the way Medichem contributes to Global Sustainability.
Many workshops organized on 28th April at different Medichem sites to help improve health and safety at work: respiratory protection, hand pro...
We are pleased to announce that the DCP Marketing Authorization related to Medichem Apixaban 5 mg and 2.5 mg film-coated tablets was grant...
Today, February 26th, Elisabeth Stampa, CEO of Medichem, has participated in the High-level launch event of the EU structured dialogue for the...
We would like to share Medicines for Europe’s press release on the EU dialogue organized by the European Commission last 26th February to disc...
Our shiny new site is now live! Check it out and discover: * Our customers' stories and how we go “beyond the pill” by providing unique benef...
This year has certainly been extraordinary and we would like to express our deep gratitude for your trust. We wish you an enjoyable holiday seas...
We strive to reach the United Nations Sustainable Development Goals and integrate them into our daily operations. This month, we would like to t...
On October 7th, Medichem participated in the conference for a #healthyeurope to discuss how European industrial policy should strengthen API supp...
Sugammadex Sodium is an injectable solution indicated for the reversal of neuromuscular blockade in anesthesia. Medichem is a vertically ...
Auditors have praised Medichem’s environmental management system after this year’s follow-up certification audit (for ISO 14001: 2015) of the pro...
Sunitinib malate is an oral tyrosine kinase inhibitor (TKI) used to treat renal carcinoma and gastrointestinal stromal tumors. Medichem’s Suniti...
As part of our work with @Medicines for Europe, we have developed a policy roadmap for medicines manufacturing in Europe. The #COVID19 crisis has ...
Medichem´s DMFs for the Active Pharmaceutical Ingredient of Paroxetine and Rivaroxaban are filed and listed on the CDE website, China – Q...
Dear Customer, Like many of you we have been closely following the developments about coronavirus. At Medichem we deeply care about our ...
Medichem receives the Approval Notice Letter by the Korean Authorities for Apixaban´s Active Pharmaceutical Ingredient – Q4’19 Mediche...
What could be more inspiring than the ESADECREAPOLIS meeting rooms for Medichem's R&D and Business Development summit? On July 9th and 10th,...
"USP’s Donor Recognition Program would like to recognize Medichem for its contributions during the 2018 calendar year" Says...
On June 26th, Medichem participated in a Design Thinking Workshop organized by Ship2B. In line with Medichem´s Culture of ...
Medichem has carried out a project from 2016- till 2017 to expand the production capacity of its plant in Celrà, which...
A favorable US FDA inspection at Medichem’s subsidiary Combino Pharm’s plant in Malta opens the door to the commercializati...
We are proud to announce that Medichem Manufacturing (Malta) Ltd. has been one of sponsors of this year's annual National Chemistry Symposium, orga...
The latest US FDA inspection of our plant in Celrà (Girona), Spain in April resulted in no “Form 483” (no observations were noted). For the Celrà s...
We are happy to announce the launch of our Medichem’s new website which uses our new corporate identity.
Flow Chemistry is a technique involving the use of structured devices, also called microreactor or flow reactors, where reactants are combined and ...
FACTS ABOUT CHLORHEXIDINE IN ORAL CARE Chlorhexidine is an antiseptic and antimicrobial often used as an active ingredient in oral rinse. ...
Medichem Malta plant passed a US FDA inspection for the second consecutive time without receiving any observation. The inspection of Medichem’s pl...
In May 2014, Medichem opened a brand new High Potency API unit (HPAPI) in its Maltese plant, located in Hal Far. The HPAPI modular laboratory is a ...
The latest FDA inspection of our plant in Celrà (Girona), Spain in September resulted in no “Form 483” (no observations were noted). The inspectio...
The latest FDA inspection of our plant in Hal Far (Malta) in April resulted in no “Form 483” (no observations were noted). Times of Malta
This year, we celebrate our 40th anniversary in the global pharmaceutical industry. During these 40 years, our goal has always been constant innov...
The latest FDA inspection of our Spanish plant in Celrà (Girona) in April resulted in no form 483 (no observations were noted) for the fourth conse...
The Malta plant in Hal Far, which started operations in November 2005, received FDA inspection in December 2007
The latest FDA inspection of our plant in Celrà in Spain conducted in November resulted in no form 483 (no observations were noted) for the third c...
Medichem inaugurated its new production plant in Hal Far in Malta in November 2005. The plant is equipped with the state-of-the-art equipment and ...
On 10th November His Excellency Dr. Edward Fenech-Adami, President of Malta, paid a visit to our facilities in Celrà, Spain. President Fenech Adami...
Since 1985 our plant in Celrà in the province of Girona in Spain has been regularly inspected and found acceptable by the FDA. For the second cons...
post of